Edgewise Therapeutics, Inc. (EWTX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
37. 19
-1.01
-2.644%
$
4.2B Market Cap
- P/E Ratio
- Div Yield
1.14M Volume
-1.72 Eps
$ 38.2
Previous Close 
Want to track EWTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Edgewise Therapeutics, Inc. (EWTX) Statistics
Valuation metrics
Market Cap 4.2B
Enterprise value 4.13B
Trailing P/E (ttm) -21.11
Forward P/E -
PEG ratio 1.21
Price/Sales (ttm) -
Price/Book (mrq) 9.39
Enterprise Value/Revenue -
Enterprise Value/EBITDA -21.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.17M
Average volume (90 days) 1.03M
Price summary
52-Week low 14.68
52-Week high 48.51
Beta -
50-Day moving average 39.77
200-Day moving average 34.15
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 16.24%
Book value per share (mrq) 4.16
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
